The coffee advice given to atrial fibrillation patients may deserve a rethink
A randomized trial challenges decades of caution about caffeine, finding that modest daily coffee intake did not worsen…
Woman becomes first to receive pioneering new cancer therapy
A woman with advanced ovarian cancer has become the first patient in the world to receive a pioneering…
Major Alzheimer’s breakthrough as new drug could stop disease
A new drug could stop Alzheimer’s before symptoms show. Around 1,600 people will be offered the drug in…
Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously…
New Baldness Pill Boosts Hair Coverage by Up to 86% in Six Months
AI-generated image. A familiar hair-loss drug may be getting a major upgrade. A slow-release formulation of minoxidil, one…
Hormone cycles dictate how the brain absorbs neuroprotective drugs
Consider what we ask of a clinical trial. We gather people who differ in nearly every way that…
Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
Rein Therapeutics 16 patients enrolled to date in trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) First patient…
The Liver Doc on his fight against pseudoscience, wellness myths and powerful interests
A 14-year-old girl walks into his ward with severe liver damage. The culprit? Traditional herbal medicine sold freely…
‘Cancer Bush’ shows promise as complementary medicine to chemotherapy
A plant found across South Africa and long used in traditional medicine could one day help fight some…
An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity…
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., May 27, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
J&J starts head-to-head PFA trial against Boston Scientific device
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free…